Purchase Order 75N94023P00358
- Not listed
- This federal contract award, valued at $14,409.02, was issued by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) to Bruker Biospin Corp, a subsidiary of Bruker Corporation. The contract is for the procurement of an ATM unit for probe Z151032/0001, with a completion date of September 30, 2023. The contract type is a Purchase Order with a Firm Fixed Price pricing structure. This award was not designated as a set-aside contract. Bruker Corporation is a global scientific...
- This federal contract award was issued by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), a civilian agency, to Bruker Biospin Corp, a subsidiary of the Bruker Corporation. The $322,000.00 firm fixed-price purchase order is for the delivery of scientific instrumentation, primarily nuclear magnetic resonance (NMR) spectrometers, magnetic resonance imaging (MRI) systems, and electron spin resonance (EPR) spectrometers. This award was not set aside and was competed...
- The Department of Health and Human Services National Institutes of Health National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) awarded a $230,346.00 firm-fixed-price purchase order to Bruker Biospin Corp, a for-profit manufacturer of scientific instruments. The contract is for the provision of an NMR accessory MAS probe. The place of performance is Bethesda, Maryland. The contract does not have a set-aside designation. Bruker Biospin Corp is a subsidiary of the Bruker...
- The Department of Health and Human Services' National Institute of Diabetes and Digestive and Kidney Diseases awarded a $15,514 firm fixed-price purchase order to Bruker Biospin Corp. for an AQS REFERENCE BOARD/3 1200. Bruker Biospin Corp. is a subsidiary of Bruker Corporation located in Billerica, Massachusetts. The order is to be completed by September 30, 2023 in support of NIDDK programs. No set-aside designation or subcontractors were identified. The award provides the research equipment...
- This federal contract award, valued at $440,500.00, was issued by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) to Bruker Biospin Corp, a manufacturer of scientific instruments. The award is for the purchase of an AVANCE III HD 600 console, as described in the associated quote. The end user is Gideon Clore, and the contract does not have a set-aside designation. Bruker Biospin Corp is known to provide nuclear magnetic resonance spectrometers, upgrades, maintenance,...
- The National Institute of Diabetes and Digestive and Kidney Diseases, a civilian agency, awarded a $185,250 firm fixed-price purchase order to Bruker Biospin Corp, a for-profit manufacturer, for the delivery of a nuclear magnetic resonance (NMR) spectrometer. This award is not associated with any set-aside program. Bruker Biospin Corp is a subsidiary of the larger Bruker Corporation, which provides a wide range of analytical and detection equipment and services to various U.S. government...
- This federal contract award is for the repair of a 700 MHz Model Z151032 cryoprobe by Bruker Biospin Corp, a subsidiary of Bruker Corporation. The $2,350 firm fixed-price purchase order was awarded on March 2, 2018, with an ultimate completion date of April 2, 2018. The contract was awarded by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), a civilian agency under the National Institutes of Health (NIH). Bruker Biospin Corp is an experienced provider of scientific...
- The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) has awarded a $216,684 firm-fixed price purchase order to Bruker Biospin Corp. for a CryoPlatformTM Maintenance Agreement. This agreement will provide critical maintenance services for the agency's Nuclear Magnetic Resonance (NMR) spectrometers used in protein research. Bruker Biospin Corp. is the sole source provider of the proprietary CryoPlatform equipment and authorized maintenance services. This purchase order does...
- This is a firm-fixed-price purchase order contract awarded by the Department of Health and Human Services' National Institutes of Health National Institute on Drug Abuse to Bruker Biospin Corp, a manufacturer of scientific instruments and provider of specialized equipment, maintenance, and support services. The contract, valued at $116,519.22, is for the provision of nuclear magnetic resonance spectrometers, upgrades, maintenance, and related services. Bruker Biospin Corp, a subsidiary of Bruker...
- The National Institute of Diabetes and Digestive and Kidney Diseases awarded a $10,600 purchase order contract to Bruker Biospin Corp, a subsidiary of Bruker Corporation, for a sample protection system for a Bruker 500 nuclear magnetic resonance (NMR) spectrometer. This contract was not associated with any set-aside program. Bruker Corporation is a major supplier of scientific instrumentation, including NMR spectrometers, mass spectrometry systems, X-ray diffraction equipment, and specialized...
This federal contract award, valued at $14,409.02, was made by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) to Bruker Biospin Corp, a subsidiary of Bruker Corporation. The contract is for the procurement of an Automated Tube Measurement (ATM) module for an NIH probe. This purchase order is a firm fixed-price contract with a completion date of November 1, 2023. The award did not utilize any set-aside designations. Bruker Biospin Corp is a manufacturer of scientific instruments, including nuclear magnetic resonance (NMR) spectrometers, magnetic resonance imaging (MRI) systems, and electron spin resonance (EPR) spectrometers, which are commonly used in federal research programs. The parent company, Bruker Corporation, has extensive experience providing specialized scientific equipment and support services to various government agencies, including the Department of Defense, Department of Homeland Security, and National Institutes of Health.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $14.4k | 5/5/23 |